An improved flow cytometric method using FACS Lysing Solution for measurement of ZAP‐70 expression in B‐cell chronic lymphocytic leukemia
- 15 August 2007
- journal article
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 74B (1) , 40-44
Abstract
Background: B‐cell expression of ZAP‐70, normally expressed in T and NK cells, correlates with poor prognosis in B‐CLL. Poor discrimination between ZAP‐70 positive and negative cells hampers routine application of flow cytometry. We examined the usefulness of FACS Lysing Solution. Methods: ZAP‐70 expression in 65 healthy volunteers was measured by four‐color flow cytometry, comparing FACS Lysing Solution for fixation and permeabilization with the Fix & Perm kit. Separation between ZAP‐70 positive T cells and negative B cells was based on a ratio of median ZAP‐70 staining of T cells to B cells. In 25 B‐CLL patients, ZAP‐70 expression was estimated using the lower limit of the fluorescence range corresponding with 98% of ZAP‐70 positive T cells as threshold marker as well as a ratio of B‐CLL cell to internal T‐cell median ZAP‐70 staining. Results: Use of FACS Lysing Solution resulted in approximately fourfold increased separation between ZAP‐70 positive T cells and negative B cells, when compared with the Fix & Perm kit. In B‐CLL samples, ZAP‐70 negative and positive B‐cell expression could be clearly discerned. Conclusions: FACS Lysing Solution is a simple procedure that markedly improves discrimination between ZAP‐70 positive and negative cells. © 2007 Clinical Cytometry Society.Keywords
This publication has 17 references indexed in Scilit:
- Discordant results of flow cytometric ZAP‐70 expression status in B‐CLL samples if different gating strategies are appliedCytometry Part B: Clinical Cytometry, 2006
- ZAP‐70 by flow cytometry: A comparison of different antibodies, anticoagulants, and methods of analysisCytometry Part B: Clinical Cytometry, 2006
- Evaluation of ZAP‐70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization processCytometry Part B: Clinical Cytometry, 2006
- Use of a blocking antibody method for the flow cytometric measurement of ZAP‐70 in B‐CLLCytometry Part B: Clinical Cytometry, 2006
- B lymphocytes in humans express ZAP‐70 when activated in vivoEuropean Journal of Immunology, 2006
- Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratoryClinical and Laboratory Haematology, 2005
- ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotypeLeukemia, 2005
- Intracellular phospho‐protein staining techniques for flow cytometry: Monitoring single cell signaling eventsCytometry Part A, 2003
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chainCell, 1992